Evaluation of commercially available assays for the measurement of equine insulin

Domestic Animal Endocrinology

Volumn 41, Issue 2, 2011, Pages 81-90

  Tinworth, K D ^a   Wynn, P C ^a   Boston, R C ^b   Harris, P A ^c   Sillence, M N ^d   Thevis, M ^e   Thomas, A ^e   Noble, G K ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WALTHAM CENTRE FOR PET NUTRITION   (United Kingdom)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Accuracy; Assay validation; Hyperinsulinemia; Immunoassay; Precision

Indexed keywords

INSULIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; COMPARATIVE STUDY; EVALUATION; HORSE; RADIOIMMUNOASSAY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANIMALS; HORSES; INSULIN; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EQUIDAE;

EID: 79960097879     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2011.05.001     Document Type: Article

References (36)

1. Johnson P.J. The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am Equine Pract 2002, 18:271-293.
2. Asplin K.E., Sillence M.N., Pollitt C.C., et al. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Vet J 2007, 174:530-535.
3. de Laat M., McGowan C., Sillence M., et al. Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses. Equine Vet J 2010, 42:129-135.
4. Treiber K.H., Kronfeld D.S., Geor R.J. Insulin resistance in equids: possible role in laminitis. J Nutr 2006, 136:2094S-2098S.
5. Ralston S., Black A., Suslak-Brown L., et al. Postprandial insulin resistance associated with osteochondrosis in weanling fillies. J Anim Sci 1998, 76:176.
6. Frank N. Equine metabolic syndrome. J Equine Vet Sci 2009, 29:259-267.
7. McGowan C.M., Frost R., Pfeiffer D.U., et al. Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. Equine Vet J 2004, 36:295-298.
8. Conlon J.M. Evolution of the insulin molecule: insights into structure-activity and phylogenetic relationships. Peptides 2001, 22:1183-1193.
9. McGowan T., Geor R., Evans H. Comparison of 4 assays for serum insulin analysis in the horse. ACVIM Forum, Texas 2008, San Antonio, Texas.
10. Deshpande S.S. Enzyme Immunoassays: From Concept to Product Development 1996, Chapman & Hall, New York.
11. Kemeny D., Challacombe S. ELISA and Other Solid Phase Immunoassays:Theoretical and Practical Aspects 1989, John Wiley & Sons, Chichester.
12. Bangham D.R., Cotes P.M. Standardization and standards. Br Med Bull 1974, 30:12-17.
13. Freestone J.F., Wolfsheimer K.J., Kamerling S.G., et al. Exercise induced hormonal and metabolic changes in Thoroughbred horses: effects of conditioning and acepromazine. Equine Vet J 1991, 23:219-223.
14. Vick M.M., Adams A.A., Murphy B.A., et al. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J Anim Sci 2007, 85:1144-1155.
15. Bailey S.R., Menzies-Gow N.J., Harris P.A., et al. Effect of dietary fructans and dexamethasone administration on the insulin response of ponies predisposed to laminitis. J Am Vet Med Assoc 2007, 231:1365-1373.
16. Treiber K.H., Kronfeld D.S., Hess T.M., et al. Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am J Vet Res 2005, 66:2114-2121.
17. Frank N., Elliott S.B., Boston R.C. Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses. Am J Vet Res 2008, 69:76-81.
18. Hodavance M.S., Ralston S.L., Pelczer I. Beyond blood sugar: the potential of NMR-based metabonomics for type 2 human diabetes, and the horse as a possible model. Anal Bioanal Chem 2007, 387:533-537.
19. Carter P. Preparation of ligand-free human serum for radioimmunoassay by adsorption on activated charcoal. Clin Chem 1978, 24:362-364.
20. Albano J.D., Ekins R.P., Maritz G., et al. A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) 1972, 70:487-509.
21. Clarke H.G., Freeman T. Quantitative immunoelectrophoresis of human serum proteins. Clin Sci 1968, 35:403-413.
22. Arquilla E.R., Tranquada R.E., Beigelman P.M., et al. Studies on a heat labile factor which influences the reaction between insulin and antibody from diabetic patients. Diabetes 1962, 11:183-191.
23. Caraway W. Carbohydrates. Fundamentals of Clinical Chemistry 1976, 234-263. Saunders, Philadelphia. N. Tietz (Ed.).
24. Lin L.I. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989, 45:255-268.
25. Thevis M., Thomas A., Delahaut P., et al. Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes. Anal Chem 2005, 77:3579-3585.
26. Thomas A., Schanzer W., Delahaut P., et al. Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution/high-accuracy mass spectrometry. Drug Test Anal 2009, 1:219-227.
27. Porcine Insulin ELISA Package Insert 2008, Shibayagi Co, Shibayagi Co, Gunma.
28. Noble G.K., Sillence M.N. Technical considerations when measuring IGF-1 and IGF binding proteins in the horse. Proceedings of the 13th Interntational Conference of Racing Analysts and Veterinarians 2000, 314-320. R and W Publications, Newmarket, UK, UK.
29. Tinworth K.D., Wynn P.C., Harris P.A., et al. Optimising the Siemens Coat-A-Count radioimmunoassay to measure insulin in equine plasma. J Equine Vet Sci 2009, 29:411-413.
30. Borer K.E., Berhane Y., Menzies-Gow N.J., et al. Measurement of concentrations of insulin in equine serum that exceed the working range of radioimmunoassay kits. British Equine Veterinary Association Congress 2009, Birmingham, UK.
31. Thevis M., Thomas A., Schänzer W. Mass spectrometric determination of insulins and their degradation products in sports drug testing. Mass Spectrom Rev 2008, 27:35-50.
32. Kuuranne T., Thomas A., Leinonen A., et al. Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing. Rapid Comm Mass Spectrom 2008, 22:355-362.
33. Tinworth K.D., Glowacki L., Boston R.C., et al. Evaluation of commercially-available cortisol assays being used to measure equine cortisol. Australasian Equine Science Symposium 2010 2010, Gold Coast, Australia.
34. Andersen L., Jorgensen P.N., Jensen L.B., et al. A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies. Clin Biochem 2000, 33:627-633.
35. Sink T.D., Lochmann R.T., Fecteau K.A. Validation, use, and disadvantages of enzyme-linked immunosorbent assay kits for detection of cortisol in channel catfish, largemouth bass, red pacu, and golden shiners. Fish Physiol Biochem 2008, 34:95-101.
36. Clemmons D.R. IGF-I assays: current assay methodologies and their limitations. Pituitary 2007, 10:121-128.